← Back to Search

Hydrogel Dressing

Transforming Powder Dressing for Pressure Sores

N/A
Waitlist Available
Led By Saxe Johathan, MD
Research Sponsored by ULURU Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate the effectiveness of Altrazeal® for patients with severe pressure ulcers. Altrazeal® is a powder that forms a protective cover over wounds, helping them heal. The study aims to see if Altrazeal® can reduce dressing changes and improve healing. Altrazeal® offers a promising new form of wound treatment.

Eligible Conditions
  • Bed sore
  • Bedsores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of wound dressing changes
Secondary study objectives
Complications (problems) from treating the pressure wound
Pain in the wound and from dressing changes.
Wound Quality of Life
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Altrazeal® Transforming Powder DressingActive Control1 Intervention
Altrazeal® Transforming Powder Dressing will be applied during the Baseline visit. It should be left in place for up to 30 days, and topped off (additional powder applied if needed) at each subsequent visit. Secondary dressing, including a contact layer over the Altrazeal® and a secondary dressing (like gauze or foam) may be applied over the contact layer.
Group II: Standard of Care Dressing for Pressure InjuryActive Control1 Intervention
Standard wound dressings recommended by the National Pressure Injury Advisory Panel (NPIAP), according to the wound stage, will be utilized to treat pressure injuries. These include hydrocolloid, hydrogel, polymeric membranes, foam, collagen dressings, and negative pressure wound therapy. Dressings will be changed according to wound conditions, and type of dressing selected.

Find a Location

Who is running the clinical trial?

ULURU Inc.Lead Sponsor
4 Previous Clinical Trials
303 Total Patients Enrolled
United States Department of DefenseFED
913 Previous Clinical Trials
334,006 Total Patients Enrolled
Saxe Johathan, MDPrincipal InvestigatorAltrazeal Life Sciences Inc
Lawrence Lavery, DPM, MPHPrincipal InvestigatorULURU Inc.
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

Altrazeal® Transforming Powder Dressing (Hydrogel Dressing) Clinical Trial Eligibility Overview. Trial Name: NCT05496296 — N/A
Bed sore Research Study Groups: Altrazeal® Transforming Powder Dressing, Standard of Care Dressing for Pressure Injury
Bed sore Clinical Trial 2023: Altrazeal® Transforming Powder Dressing Highlights & Side Effects. Trial Name: NCT05496296 — N/A
Altrazeal® Transforming Powder Dressing (Hydrogel Dressing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05496296 — N/A
~116 spots leftby Dec 2025